HomeQuestion

Should we be using body fat percentage instead of BMI for determining patients' risk of metabolic syndrome?

3

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Does injectable semaglutide have a higher glucose-lowering efficiency than oral semaglutide?

How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?

How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.